Among previous GLP-1 users, 49 percent experienced nausea, 33 percent had diarrhea, and 32 percent reported stomach pain
Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor
Clinical trials have highlighted MT2's efficacy, with 85% of participants reporting improved erectile function and 68% experiencing heightened sexual desire
Semaglutide reduces appetite and calorie intake, triggering fat oxidation
Recent advances in the development of new auristatins: structural modifications and application in antibody drug conjugates
Studies have shown that many people experience considerable weight reduction when using the drug, largely because of its effect on appetite and digestionit slows down how quickly food leaves your stomach, making you feel fuller for longer, which helps you to eat less